跳至主要内容
临床试验/NCT03456518
NCT03456518已完成不适用

Pattern of Acute on Chronic Liver Failure in Patient With HCV Related Chronic Liver Disease

Assiut University2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2018年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2
主要终点
pattern of acute on chronic liver cell failure

研究概览

简要总结

The concept of acute-on-chronic liver failure (ACLF) was introduced by Jalan and Williams in 2002 to describe the acute deterioration in liver function over 2 to 4 weeks in a patient with well-compensated cirrhosis associated with a precipitating event (hepatotoxic: superimposed hepatitis viral infection, drug-induced liver injury, hepatotoxins, or excessive alcohol consumption; extra hepatic: variceal bleeding or sepsis), leading to severe deterioration in clinical status with jaundice and hepatic encephalopathy and/or HRS. Following this concept, several proposals for the diagnostic criteria of ACLF have been suggested.

详细描述

There may be regional differences in etiology, pathogenesis, and natural course of ACLF, which may in turn influence the overall outcome of this syndrome. So, proper diagnosis of ACLF and its precipitating factors in our locality enable us for proper management of these cases and dealing with these precipitating factors to be avoided later on in patients with liver cirrhosis

Aim of the work:

To identify the pattern of acute on chronic liver cell failure (ACLF) within 28 days including prevalence, percipitating factors, and outcome.

Patients and methods

Type of the study: Prospective hospital based study

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult Patients with HCV related CLD based on clinical, biochemical and imaging evidence., with or without prior decompensation.
  • Patients diagnosed to have ACLIF at any grade (1-3)

排除标准

  • Acute liver failure without evidence of chronic liver disease.
  • Other etiology of chronic liver disease
  • Patients diagnosed with no ACLIF No ACLF
  • This category includes patients who either:
  • Do not have any organ failure
  • Have a single organ failure that does not involve the kidney with a serum creatinine level of <1.5 mg per dl and no hepatic encephalopathy
  • Have a single brain failure with a serum creatinine level of <1.5 mg per dl
  • Patients refuse to participate.

结局指标

主要结局

pattern of acute on chronic liver cell failure

时间窗: march 2018 to march 2019

evaluation of cases with acute on chronic liver cell failure as number of cases diagnosed with ACLF in this period , the precipitating factor of the condition , the fate of the patient (improving or deterioration or death ) in the 28 days following diagnosis .

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tasneem Khaled

resident doctor

Assiut University

研究点 (2)

Loading locations...

相似试验

已完成
不适用
Chinese CLIF-C Acute-on-Chronic Liver Disease and Liver Failure StudyLiver Failure, Acute on Chronic
NCT02457637Hai Li2,600
进行中(未招募)
1 期
Biological mechanisms of Acute on Chronic Liver Failure (ACLF) and Mechanisms of Action of Plasma Exchange with Human Serum Albumin 5% in Subjects with cirrhosis with systemic inflammation and ACLF
EUCTR2017-002677-19-ESInstituto Grifols S.A.250
进行中(未招募)
1 期
Biological mechanisms of Acute on Chronic Liver Failure (ACLF) and Mechanisms of Action of Plasma Exchange with Human Serum Albumin 5% in Subjects with cirrhosis with systemic inflammation and ACLFGroup 1 and 2:Subjects with cirrhosis with ACLF-1b, ACLF-2, or ACLF-3a detected either at admission or duringhospitalization Group 3: Subject with cirrhosis hospitalized for Acute decompensation of cirrhosis (ascites, hepatic encephalopathy [HE], gastrointestinal hemorrhage, and/or bacterial infections)MedDRA version: 20.1Level: LLTClassification code 10064704Term: Decompensated cirrhosisSystem Organ Class: 100000004871
EUCTR2017-002677-19-DEInstituto Grifols S.A.250
进行中(未招募)
1 期
Biological mechanisms of Acute on Chronic Liver Failure (ACLF) and Mechanisms of Action of Plasma Exchange with Human Serum Albumin 5% in Subjects with cirrhosis with systemic inflammation and ACLFGroup 1 and 2:Subjects with cirrhosis with ACLF-1b, ACLF-2, or ACLF-3a detected either at admission or during hospitalization Group 3: Subject with cirrhosis hospitalized for Acute decompensation of cirrhosis (ascites, hepatic encephalopathy [HE], gastrointestinal hemorrhage, and/or bacterial infections)MedDRA version: 20.1Level: LLTClassification code 10064704Term: Decompensated cirrhosisSystem Organ Class: 100000004871
EUCTR2017-002677-19-ITINSTITUTO GRIFOLS, S.A.
进行中(未招募)
1 期
Biological mechanisms of Acute on Chronic Liver Failure (ACLF) and Mechanisms of Action of Plasma Exchange with Human Serum Albumin 5% in Subjects with cirrhosis with systemic inflammation and ACLF
EUCTR2017-002677-19-ATInstituto Grifols S.A.250
Pattern of Acute on Chronic Liver Failure in Patient... | 临床试验